Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This clinical trial evaluates whether engineering gut microbiome using probiotics will alter
the body's immune system to react to stage I-III breast or lung cancers that can be removed
by surgery (operable). Having diverse species of bacteria inside the bowel may help improve
the immune system, particularly the ability of the immune system to recognize cancer. Taking
probiotics may change the diversity and make up of the bacteria in the bowels, and change how
the immune system reacts to breast or lung cancer.